RESEARCHER PROFILE
Hyun‐Ju Park
← Back to Korea University of Science and Technology
H
Korea University of Science and Technology
Hyun‐Ju Park works in Synthesis and biological activity, Computational Drug Discovery Methods, Heat shock proteins research, Science Education and Pedagogy, DNA and Nucleic Acid Chemistry. Recorded institutional associations include Korea Research Institute of Bioscience and Biotechnology, Korea University of Science and Technology.
211Publications
3,613Citations
32H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Induction of Reversible Complexes between Eukaryotic DNA Topoisomerase I and DNA-containing Oxidative Base Damages
1999 · 185 citationsIrreversible Inhibition of CD13/Aminopeptidase N by the Antiangiogenic Agent Curcumin
2003 · 168 citationsDiscovery of N -((4-([1,2,4]Triazolo[1,5- a ]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1 H -imidazol-2-yl)methyl)-2-fluoroaniline (EW-7197): A Highly Potent, Selective, and Orally Bioavailable Inhibitor of TGF-β Type I Receptor Kinase as Cancer Immunotherapeutic/Antifibrotic Agent
2014 · 162 citationsIdentification of RNA Pseudoknot-Binding Ligand That Inhibits the −1 Ribosomal Frameshifting of SARS-Coronavirus by Structure-Based Virtual Screening
2011 · 148 citationsMetabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC
2021 · 126 citationsA New Curcumin Derivative, HBC, Interferes with the Cell Cycle Progression of Colon Cancer Cells via Antagonization of the Ca2+/Calmodulin Function
2004 · 104 citationsG-Quadruplex Binding Ligands: from Naturally Occurring to Rationally Designed Molecules
2012 · 97 citationsSynthesis and biological evaluation of novel 2-pyridinyl-[1,2,3]triazoles as inhibitors of transforming growth factor β1 type 1 receptor
2004 · 85 citationsNovel Molecular Mechanism for Actinomycin D Activity as an Oncogenic Promoter G-Quadruplex Binder
2009 · 74 citationsPyrazole-5-carboxamides, novel inhibitors of receptor for advanced glycation end products (RAGE)
2014 · 65 citationsEarly Clinical and Radiologic Outcomes of Cervical Arthroplasty with Bryan Cervical Disc Prosthesis
2006 · 63 citationsLigand-Based Design, Synthesis, and Biological Evaluation of 2-Aminopyrimidines, a Novel Series of Receptor for Advanced Glycation End Products (RAGE) Inhibitors
2012 · 60 citationsA Novel Derivative of the Natural Agent Deguelin for Cancer Chemoprevention and Therapy
2008 · 59 citationsA novel HSP90 inhibitor targeting the C-terminal domain attenuates trastuzumab resistance in HER2-positive breast cancer
2020 · 59 citationsExosome-guided direct reprogramming of tumor-associated macrophages from protumorigenic to antitumorigenic to fight cancer
2022 · 57 citationsBiarylpyrazolyl Oxadiazole as Potent, Selective, Orally Bioavailable Cannabinoid-1 Receptor Antagonists for the Treatment of Obesity
2008 · 56 citationsTotal Synthesis of (+)-Brefeldin A
2002 · 52 citationsSynthesis and Biological Evaluation of 4(5)-(6-Alkylpyridin-2-yl)imidazoles as Transforming Growth Factor-β Type 1 Receptor Kinase Inhibitors
2007 · 51 citationsA novel C-terminal heat shock protein 90 inhibitor that overcomes STAT3-Wnt-β-catenin signaling-mediated drug resistance and adverse effects
2021 · 50 citationsDeguelin Analogue SH-1242 Inhibits Hsp90 Activity and Exerts Potent Anticancer Efficacy with Limited Neurotoxicity
2015 · 48 citationsHypoxia-mediated retinal neovascularization and vascular leakage in diabetic retina is suppressed by HIF-1α destabilization by SH-1242 and SH-1280, novel hsp90 inhibitors
2014 · 44 citationsSynthesis and Biological Evaluation of 3-(4-Substituted-phenyl)-N-hydroxy-2-propenamides, a New Class of Histone Deacetylase Inhibitors
2003 · 43 citationsDevelopment of a novel Hsp90 inhibitor NCT-50 as a potential anticancer agent for the treatment of non-small cell lung cancer
2018 · 40 citationsRational Design of an Indolebutanoic Acid Derivative as a Novel Aldose Reductase Inhibitor Based on Docking and 3D QSAR Studies of Phenethylamine Derivatives
2003 · 36 citationsNovel Interaction of the Z-DNA Binding Domain of Human ADAR1 with the Oncogenic c-Myc Promoter G-Quadruplex
2014 · 36 citations
